mobile-bannertablet-bannerdesktop-banner
Fortune Global Forum 2015
Elizabeth Holmes, Theranos founder and CEO  Photograph by Stuart Isett—Fortune Global Forum

Theranos May Lose Its Biggest Blood-Testing Customer

Feb 11, 2016

Walgreens Boots Alliance, the largest U.S. drugstore chain, threatened to terminate its relationship with Theranos unless the blood-testing company quickly fixes the problems found by federal inspectors at its laboratory in California, the Wall Street Journal reported.

The drugstore chain gave the warning in a letter to Theranos late last month, the Journal said, citing people familiar with the matter.

A spokesman for Walgreens declined to comment.

Walgreens (wba) had suspended laboratory services by Theranos on Jan. 28 after the U.S. Centers for Medicare & Medicaid Services said that Theranos ' deficient practices at its Newark lab posed "immediate jeopardy to patient health and safety".

Theranos has been in the spotlight after reports in the Wall Street Journal suggested that its blood-testing devices were flawed and had problems with accuracy.

The 40 Theranos "wellness centers" at Walgreens stores in Arizona are the primary source of revenue for the blood-testing company and its conduit to consumers, the newspaper said.

Theranos was unavailable for comment outside regular U.S. business hours.

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions